HTA152 Practical Challenges of Implementing a New Patient-Reported Outcome (PRO) in Oncology Under the German Pharmaceutical Market Restructuring Act (AMNOG) - Results From a Qualitative Focus Group Study
Abstract
Authors
S Pauge B Surmann A Zueger L Richter V Mathies K Mehlis T Ernst W Greiner N Menold E Winkler